Increased vancomycin dosing requirements in sickle cell disease due to hyperfiltration-dependent and independent pathways

Documenti analoghi

• Utility of the Revised Cardiac Risk Index for Predicting Postsurgical Morbidity in Hb SC and Hb Sβ(+)-thalassemia Sickle Cell Disease
  di: Rosenberg, Ari, et al.
  Pubblicazione: (2016)
• Program Expansion of a Day Hospital Dedicated to Manage Sickle Cell Pain
  di: Han, Jin, et al.
  Pubblicazione: (2017)
• Erythropoiesis-stimulating agents in sickle cell anaemia
  di: Han, Jin, et al.
  Pubblicazione: (2017)
• Patterns of Opioid Use in Sickle Cell Disease
  di: Han, Jin, et al.
  Pubblicazione: (2016)
• The Morbidity and Mortality of End Stage Renal Disease in Sickle Cell Disease
  di: Viner, Maya, et al.
  Pubblicazione: (2019)